Translate Bio, Inc.

Home » Translate Bio, Inc.

IPO

Translate Bio, Inc.

We are a leading messenger RNA, or mRNA, therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction

Symbol

TBIO

Price Range
$12.00 - $14.00

Final Shares
7,700,000

Anticipated Date
TBD

Underwriters
Citigroup, Leerink Partners, Evercore ISI

To view the prospectus for Translate Bio, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253